Company / R&D per Share
Insight Molecular Diagnostics Inc. R&D per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.56
FY2025
5-year range
$0.05 / $1.23
FY2021-FY2025
Trend
-49.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D per Share has fluctuated over the past 6 years, ranging from $0.05 in FY2022 to $1.23 in FY2023.
Based on SEC 10-K filings.
0.56 in FY2025 with a 5-year CAGR of +36.5%.
Declined from $1.23 to $0.56 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +117.8%
- 5-Year CAGR
- +36.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, r&d per share decreased 49.9% year-over-year.
- Peak r&d per share was recorded in FY2023.
- Lowest r&d per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -7.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.56 | -49.9% |
| FY2024 | $1.13 | -8.6% |
| FY2023 | $1.23 | +2154.5% |
| FY2022 | $0.05 | -61.5% |
| FY2021 | $0.14 | +19.0% |
| FY2020 | $0.12 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026